COVID-19: Shiseido releases antiseptic solution in early August: many purchase requests
COVID-19:
Shiseido:
On July 13, we announced that we will sell the disinfectant solution to the general public from the beginning of August.
First of all, we will start selling at drug stores and supermarkets in Tokyo and gradually expand the area.
Japan: Start production
Following the spread of new coronavirus infection
In April, it began producing antiseptic solutions in Japan.
So far, it has been sold to medical institutions in France and the United States.
Since there were many purchase requests from general consumers, it was decided to sell.
Designated Quasi Drugs:
The disinfectant is a designated quasi drug approved by the Ministry of Health, Labor and Welfare.
It has a capacity of 500 milliliters and will be sold together with a replacement part that can reuse the pump part.
Nihon Keizai Shimbun
https://r.nikkei.com/article/DGXMZO61431750T10C20A7EAF000
Shiseido produces antiseptic solution in France and donates it for medical use New corona receiving 20,000 pieces per week-
2020/4/3 11:30
Shiseido
On the 2nd, it was revealed that the cosmetics factory in Orleans, central France, started production of the disinfectant solution on March 26th, due to the spread of the new coronavirus.
It produces 20,000 bottles a week and donates them to local medical institutions.
The factory in the US is making adjustments to start production from around 6th.
SankeiBiz
https://www.sankeibiz.jp/smp/business/news/200403/bsc2004030500005-s1.htm